ATG4B

Cysteine protease ATG4B · Q9Y4P1 · ATG4B on Sugi Atlas →

76,874 patent compounds predicted against ATG4B, 53,392 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL143499 SCHEMBL143499 1.00 20/20
SCHEMBL176983 SCHEMBL176983 0.49 9/20
SCHEMBL176984 SCHEMBL176984 0.49 9/20
SCHEMBL91914 SCHEMBL91914 0.46 9/20
SCHEMBL82569 SCHEMBL82569 0.66 7/20
Fumaric Acid Fumaric Acid (SCHEMBL48773) 0.41 6/20
Fumaric Acid Fumaric Acid (SCHEMBL152140) 0.41 6/20
SCHEMBL177586 SCHEMBL177586 0.51 5/20
Nithiamide Nithiamide (SCHEMBL158858) 0.63 4/20
9,10-Phenanthrenequinone 9,10-Phenanthrenequinone (SCHEMBL43050) 1.00 3/20
SCHEMBL40960 SCHEMBL40960 0.87 3/20
Epalrestat Epalrestat (SCHEMBL49048) 0.76 3/20
Epalrestat Epalrestat (SCHEMBL49049) 0.76 3/20
SCHEMBL75643 SCHEMBL75643 0.59 3/20
SCHEMBL75644 SCHEMBL75644 0.59 3/20
SCHEMBL158152 SCHEMBL158152 0.58 3/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL98010) 0.57 3/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL99575) 0.57 3/20
SCHEMBL151548 SCHEMBL151548 0.55 3/20
SCHEMBL81693 SCHEMBL81693 0.53 3/20

Clinical trials — most relevant to ATG4B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection PHASE3WITHDRAWN
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients PHASE2COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer PHASE1/PHASE2COMPLETED
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer PHASE1/PHASE2COMPLETED
Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients PHASE2UNKNOWN
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia PHASE2WITHDRAWN
ATG Individualized Dosing Model in URD-PBSCT. PHASE2RECRUITING
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction EARLY_PHASE1RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
Fasting, Exercise, and Diet to Activate Autophagy in Depression nanNOT_YET_RECRUITING
The Influence of Autophagy on Fatty Liver nanUNKNOWN
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Study on the Correlation Between Alveolar Macrophage-derived Autophagosomes and the Severity of Lung Injury in ARDS nanUNKNOWN
Time Course for Fasting-induced Autophagy in Humans nanWITHDRAWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Autophagy/Apoptosis Balance in Placental Vascular Pathologies nanRECRUITING
Muscle Insulin Resistance in Aging (Mirage) nanACTIVE_NOT_RECRUITING
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Intermittent Fasting for Pancreatitis nanNOT_YET_RECRUITING
Autophagy, Oxidative Stress and Hippo Signaling in Human Aortic Aneurysm nanCOMPLETED
Autophagy Markers in Endometrial Polyps nanCOMPLETED
2-A-Day Study: Twice a Day Meals Study. nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ATG4B binder may also engage these)

ProteinNameSimilarity
Q8BGE6 1.000 Q8BGE6 →
Q6PZ02 0.996 Q6PZ02 →
A0A0G2QC33 0.994 A0A0G2QC33 →
Q6PZ03 0.985 Q6PZ03 →
Q640G7 0.982 Q640G7 →
Q6DG88 0.979 Q6DG88 →
Q5ZIW7 0.965 Q5ZIW7 →
Q5R699 0.963 Q5R699 →
Q5BJZ6 0.959 Q5BJZ6 →
Q6NYU2 0.959 Q6NYU2 →
Q80YV4 0.959 Q80YV4 →
A0FKG7 0.958 A0FKG7 →
F1N9S8 0.957 F1N9S8 →
Q6PZ05 0.956 Q6PZ05 →
HELZ Probable helicase with zinc finger domain 0.955 landscape →
Q6DFV5 0.955 Q6DFV5 →
Q8VDG3 0.954 Q8VDG3 →
Q96DT6 0.954 Q96DT6 →
Q0IIH8 0.954 Q0IIH8 →
Q9Y6W3 0.953 Q9Y6W3 →
A6H7H7 0.952 A6H7H7 →
D2XV59 0.952 D2XV59 →
Q923S8 0.952 Q923S8 →
Q9CV28 0.952 Q9CV28 →
PARN Poly(A)-specific ribonuclease PARN 0.952 landscape →
Q9Y2V0 0.952 Q9Y2V0 →
Q4A1L5 0.951 Q4A1L5 →
Q96RR1 0.951 Q96RR1 →
AASDHPPT L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 0.951 landscape →
Q9UK99 0.951 Q9UK99 →